Finally, we found that co-treatment with SMI and cisplatin enhanced lung adenocarcinoma apoptosis through regulation of Mfn2-dependent mitochondrial dynamics [Figure 6]. This evidence concerns the gene MFN2 and lung adenocarcinoma.